about
Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectivesThe Efficacy and Safety of Antiinterleukin 13, a Monoclonal Antibody, in Adult Patients With Asthma: A Systematic Review and Meta-AnalysisRole for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesisAsymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)Role of alveolar macrophages in chronic obstructive pulmonary disease.Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.L-ornithine derived polyamines in cystic fibrosis airwaysAugmentation of arginase 1 expression by exposure to air pollution exacerbates the airways hyperresponsiveness in murine models of asthmaLabel-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.Regulatory haplotypes in ARG1 are associated with altered bronchodilator response.Arginase in retinopathy.Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.Arginine metabolic endotypes in pulmonary arterial hypertension.Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosisCNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain agingCompetitive metabolism of L-arginine: arginase as a therapeutic target in asthma.Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways.Ozone-induced injury and oxidative stress in bronchiolar epithelium are associated with altered pulmonary mechanics.Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.Phosphorylation inactivation of endothelial nitric oxide synthesis in pulmonary arterial hypertension.Arginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Asthma management in sickle cell diseaseAdmission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling.Role of arginase in asthma: potential clinical applications.Modulation of Asthma Pathogenesis by Nitric Oxide Pathways and Therapeutic OpportunitiesIn ovo L-arginine supplementation stimulates myoblast differentiation but negatively affects muscle development of broiler chicken after hatching.Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Oscillatory shear stress-induced arginase activity may explain reduced exhaled nitric oxide levels after vest chest physiotherapy in cystic fibrosis.Indian women of childbearing age do not metabolically conserve arginine as do American and Jamaican women.Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.Arginase and arginine dysregulation in asthma.Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score.Direct inhibition of arginase attenuated airway allergic reactions and inflammation in a Dermatophagoides farinae-induced NC/Nga mouse model.Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation.The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
P2860
Q24650052-BE064003-5FE4-4371-B439-F94D7B46B40CQ26766300-4052782B-686D-4EEA-B2E6-CD8C6689E76CQ33569387-76509438-CE87-460F-96F4-6088FC3D8CF5Q33580586-BBB6C181-EEFF-47CB-937E-AE263B525F89Q34159624-FFE66AFD-E0A0-4648-AA91-5611663AA8C6Q34190597-1A9B0501-79DE-4AC0-A88D-06AFB35B8AF8Q34447280-3BB4380B-4EE3-4686-8F23-BF17C550FE70Q34567196-8C479984-3C9B-4CC3-BC23-063FCEC1975EQ34634938-8CFE1BCE-4A02-4DF3-944C-196DE23E1432Q34665101-5FD01BC1-DB3C-4386-B849-992A5A444868Q34800913-1DB3D4E6-572A-4EF6-989C-500569B8F3A3Q35071370-80112B98-87B7-4823-92F6-4DC791027574Q35517452-CEA750B8-C4EA-4E70-92C8-7E8C654C5628Q36335912-118E9F3F-1880-48D2-ADDC-F3B66AA4BDAFQ36598397-C599BD6C-BD7A-4786-A3F2-118AD51C888FQ36682074-B2BE6B55-4415-458D-BEB6-D794517AB78AQ36682162-25BA32FC-CA9A-4643-BDFC-59737C267C03Q36873766-870A953F-1361-4C03-8DD7-65C188999F31Q36937623-50DD248D-B4D2-4660-AAB6-9DE402EF7D11Q37071749-83971434-BBBB-4113-94D5-7727EDFC614EQ37076835-46D8D81F-FE3F-4414-AC85-EACEF390079FQ37102697-B106A555-1C71-4032-BA32-C84E51597947Q37346672-3677168A-F3CE-4D04-9B8D-3FA94157228AQ37602513-D691A99D-A546-42F9-A78B-EC4925B9B9AAQ37823027-A35CF869-6252-4160-BADC-3B3D9DA7EA25Q37960068-09B928E3-D688-47ED-A2DD-60B9EBDF8158Q38131483-D16D5816-067C-4099-99C8-528CF8EFCA71Q38414121-ABD103BE-008E-4DE2-A0C3-31CE2F919475Q38635782-84E5E939-2FAF-4FD9-A162-C2D3605942C6Q38922339-118FEA7E-B4EA-4A6C-A794-61A8BB38B891Q39120172-CC33C17C-482A-4614-83E8-13606A9F37BAQ39226887-EE51355D-3E31-4BF6-B1C9-6B8176F5566DQ40863905-582E7561-5889-4C33-A6ED-F2F27E1FA684Q41831572-C4CDA4B4-8238-4312-B83F-63626ED353C9Q41971809-1286E94F-A546-4EA4-8F85-F1FD2E8AD0D5Q42282467-4437EC60-5F4F-4701-A433-7BBD1D59DCF7Q43103711-03AAAABD-F1E7-41B9-932C-9331AEB84557Q46516143-8FD60C4C-2BF4-49B4-9FDF-1FA414A7728EQ47662026-B2FE0159-EAEE-46E0-8938-589358B2ED8CQ47799282-F48CEB1F-509F-4764-BE38-35FD70CB7685
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Arginase and pulmonary diseases
@ast
Arginase and pulmonary diseases
@en
Arginase and pulmonary diseases
@nl
type
label
Arginase and pulmonary diseases
@ast
Arginase and pulmonary diseases
@en
Arginase and pulmonary diseases
@nl
prefLabel
Arginase and pulmonary diseases
@ast
Arginase and pulmonary diseases
@en
Arginase and pulmonary diseases
@nl
P2093
P2860
P921
P3181
P1476
Arginase and pulmonary diseases
@en
P2093
Harm Maarsingh
Herman Meurs
Tonio Pera
P2860
P2888
P304
P3181
P356
10.1007/S00210-008-0286-7
P407
P577
2008-08-01T00:00:00Z
P5875
P6179
1048561262